Home LiteratureArticle Details
PMID: 28870907 Published · ppublish English Journal Article

Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer.

Anticancer research ·Vol. 37 ·No. 9 ·2017-00-00 ·Pages 4867-4871

Divella R, Daniele A, DE Luca R, Simone M, Naglieri E, Savino E, Abbate I, Gadaleta CD, Ranieri G

Abstract

Colorectal cancer is the most common cancer of the gastrointestinal system and has a marked preference to metastasize to distant organs. In this study, we investigated whether levels of circulating serum pro-angiogenic cytokine such as chemokine (C-X-C motif) ligand 1 (melanoma growth-stimulating activity, alpha; CXCL1) and vascular endothelial growth factor (VEGF) have a role in favoring the colonization of metastatic cells at preferential sites and determined their prognostic significance in a cohort of 103 patients with metastatic colorectal cancer. Importantly, we found that the presence of elevated circulating levels of VEGF and CXCL1 are predictive of liver and lung metastasis, respectively. Moreover, the presence of a high serum VEGF level represents a negative prognostic factor for patients with liver metastases, with a worse prognosis than patients with lung metastasis. This suggests an additional role for circulating cytokines as a predictive tool for cancer prognosis and diagnosis, as well as for assessment of tumor sensitivity to anticancer therapy.

Keywords
CXCL1 Metastasis VEGF angiogenesis
MeSH Terms
Adult Aged Aged, 80 and over Chemokine CXCL1/blood Colorectal Neoplasms/blood,pathology Female Humans Liver Neoplasms/blood,secondary Lung Neoplasms/blood,secondary Male Middle Aged Neoplasm Metastasis Prognosis Survival Analysis Vascular Endothelial Growth Factor A/blood
Chemicals
CXCL1 protein, human Chemokine CXCL1 Vascular Endothelial Growth Factor A
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Divella Rosa
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy [email protected].
Daniele Antonella
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
DE Luca Raffaele
Department of Surgery Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Simone Michele
Department of Surgery Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Naglieri Emanuele
Department of Medical Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Savino Eufemia
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Abbate Ines
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Gadaleta Cosmo Damiano
Diagnostic and Interventional Radiology Unit with Integrated Section of Translational Medical Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Ranieri Girolamo
Diagnostic and Interventional Radiology Unit with Integrated Section of Translational Medical Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Article Info
Journal
Anticancer research
Abbr.
Anticancer Res
ISSN
1791-7530
Published
2017-00-00
Pages
4867-4871
Language
English
Region
Greece
NLM ID
8102988
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]